| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b90c4390553aaf410c2f9747b99f574c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_725cd96abf8771e58575b165a6474cd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e455a27366ca3e7bcc139ab7db86b11e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcb0d20674de393bafa2f0033cb063d9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B19-00 |
| filingDate |
2006-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cb6484a99b889ea0a5a2cff12fc1ba9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3920e3c3a2aa22e01b2dfe30e158d409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd650ef19e6af4d45b33ef34fbdd6bba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9de9d45b6dcd5def2f5fa8f541db8d25 |
| publicationDate |
2007-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007012323-A1 |
| titleOfInvention |
Compositions and methods for treating a damaged cardiovascular element |
| abstract |
In the present invention, the applicants describe methods and compositions of treating damaged cardiovascular elements and cardiovascular conditions including hypotension, atherosclerotic lesions, vulnerable plaque, and acute myocardial infarct. The applicants demonstrate the ability of a biomembrane sealing agent to accumulate on the walls of damaged blood vessels and help improving mean arterial pressure following tissue injury. The applicants describe the use of formulations comprising at least one biomembrane sealing agent and one bioactive agent for prophylactic treatment such as they could be administered concurrently to an invasive therapeutic intervention or after the insult (i.e. post-injury or post-surgery). Alternatively, these methods and compositions could be used to reduce the severity of cardiovascular diseases after onset. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011189266-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9244060-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9597352-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2410907-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006280718-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010247441-A1 |
| priorityDate |
2005-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |